N@N

Xenos Reports Preliminary F09 Q4 and Year End Results

_{//science-technology.news-articles.net/content/2 .. rts-preliminary-f09-q4-and-year-end-results.html}
^{Published in Science and Technology on Tuesday, December 8th 2009 at 13:51 GMT by Market Wire}  

 Financial Highlights: ------------------------------------------------------------------------- Period Ended September 30, FY2009 FY2008 (in CDN$000s) Sales 17,247 15,908 Cost of sales 2,848 3,419 Sales and marketing 5,829 4,895 Research and development 3,836 3,202 Administration and general 2,181 2,177 Amortization 823 945 Stock based compensation 104 97 Interest and bank charges 45 81 Operating expenses 15,666 14,816 Income from operations 1,581 1,092 (% of total sales) 9% 7% ------------------------------------------------------------------------- Revenue by Geography North America 11,360 9,364 International 5,887 6,544 --------------------- 17,247 15,908 --------------------- ------------------------------------------------------------------------- (in CDN$000s except per share amounts) FY2009 FY2008 Cash 9,311 8,115 Trade receivables 2,877 2,472 Intangibles 2,083 1,999 Other assets 3,243 2,922 --------------------- Total Assets 17,514 15,508 --------------------- Payables and accruals 2,647 2,483 Capital lease obligations 3 64 Deferred revenue 3,716 3,114 Shareholders' equity 11,148 9,847 --------------------- Total Liabilities & Shareholders' Equity 17,514 15,508 --------------------- Cash per Share $0.93 $0.81 Common Shares Outstanding 10,005 10,005 -------------------------------------------------------------------------